Call our 24 hours, seven days a week helpline at 800.272.3900

24/7 Helpline 800.272.3900
Donate

It’s a New Day in the Fight Against Alzheimer’s — Aducanumab Approved

It’s a New Day in the Fight Against Alzheimer’s — Aducanumab Approved
Share or Print this page
Share or Print this page

The Food and Drug Administration (FDA) approval of aducanumab (AduhelmTM) from Biogen — the first drug to slow the progression of Alzheimer’s disease — is a milestone in the treatment of the disease and a beginning of a completely new future for Alzheimer’s treatments. This treatment, while not a cure, is pivotal and current progress in science is significant. We expect this will be the first of a number of treatments to come.

A new type of Alzheimer’s treatment, aducanumab addresses the disease in a way that has never been done before. This therapy slows progression of the disease, rather than only addressing symptoms.

“On behalf of those impacted by Alzheimer’s and all other dementia, the Alzheimer’s Association welcomes and celebrates the historic FDA approval of aducanumab," said Harry Johns, president and CEO of the Alzheimer's Association. "This approval is a victory for people living with Alzheimer’s and their families."

The fight to end Alzheimer’s is as urgent as ever. As the leader in ending Alzheimer’s, the Alzheimer’s Association won’t stop fighting until a day without Alzheimer’s and all other dementia becomes a reality with effective treatment options for diverse populations living in all stages of Alzheimer’s.

Better Health Outcomes Through Earlier Diagnosis and Treatment

Early detection in Alzheimer’s disease is important now more than ever with a treatment available. Early diagnosis has long demonstrated better health outcomes for individuals and their caregivers. If you or a loved one is experiencing memory changes, the Alzheimer’s Association strongly encourages speaking with a health care provider for a thorough evaluation, diagnosis and to discuss treatment options.

Learn More About Aducanumab
 

Alzheimer’s and Dementia Resources

 

What is Mild Cognitive Impairment (MCI)?

Learn about MCI symptoms, diagnosis and how this disorder relates to Alzheimer's and other dementias.

 

The 10 Warning Signs of Alzheimer’s

Your memory often changes as you grow older. But memory loss that disrupts daily life is not a typical part of aging.

 

ALZ Talks: New Advancements in Alzheimer’s Treatments

Join us to learn about the new FDA-approved treatment for Alzheimer's, plus resources and support through the Alzheimer's Association.

Talk with a Dementia Expert Now

24/7 Helpline
800.272.3900

 

About the Alzheimer’s Association

The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®.


Keep Up With Alzheimer’s News and Events